Previous 10 | Next 10 |
This article was highlighted for PRO+ subscribers, Seeking Alpha’s service for professional investors. Find out how you can get the best content on Seeking Alpha here . 2019 was difficult for short-sellers considering what ended up being a historically strong year for the...
SAN FRANCISCO , Feb. 5, 2020 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that it will report its fourth quarter and full year 2019 financial results on Wednesday, February 19, 2020 and will host a conference call and ...
Investors interested in the life sciences are well aware of the importance that biotechnology and biotech companies have in this area of investment. From finding cures for disease to feeding future generations, there are many areas of day-to-day life that are influenced by biotechnology. ...
I Don’t Feel Comfortable in Info and Data Tech at These Levels My go-to “fast-Money trades” are the chips, software and Internet-enabled business stocks. I understand the underlying economics, and that gives me the comfort to be aggressive when conditions call for it...
Tepper and Druckenmiller Used the Metaphor of “Still Riding This Horse” This morning on CNBC, in anecdotes quoted by Squawkbox host Joe Kernen: David Tepper: “I like being on a horse that is running.” “We have been Long and continue that wayȁ...
Let’s Just Say That I’m Early Right now, there are just no negatives ahead of us. Earnings so far are surprising to the upside, starting with the big financial names. This opens a window into the health of the economy from a macro perspective. The big banks are doing really...
The following slide deck was published by Invitae Corporation in conjunction with this Read more ...
The opportunity in Interpace ( IDXG ) represents highly compelling upside at a very favorable entry. At about $70 million market cap (fully diluted pro forma for the recent financing), just a move to lower end peer multiples can almost triple the value of the company to be conservative even ...
One of Monday's biggest winners was genetic testing company Invitae ( NVTA ). Shares rallied more than 10% after management gave some details on current and potential future results, including guidance that was seen as favorable for 2020. While investors may be cheering the rosy forecast, th...
Adaptimmune Therapeutics PLC (NASDAQ: ADAP ) +56% as SPEAR T-cell platform delivers initial responses in four solid tumors. More news on: Adaptimmune Therapeutics plc, Verona Pharma plc, Mereo BioPharma Group plc, Stocks on the move, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Labcorp Announces Winning Bid for Select Assets of Invitae PR Newswire Advances Labcorp strategy to launch and scale specialty testing in areas such as oncology and rare diseases Transaction requires court approval, with confirmation expected on May 6, 2024 ...
Invitae Enters into Agreement with Labcorp for Sale of Business PR Newswire – Labcorp Selected as Winning Bidder in Court-Supervised Sale Process, Subject to Court and Regulatory Approvals – – $239 Million Cash Bid Includes Acquisition of Substantial...
Invitae Unveils New Research for Breast Cancer Patients with Variants of Uncertain Significance PR Newswire – Study findings to be presented at the 2024 American Society of Breast Surgeons Annual Meeting – SAN FRANCISCO , April 11, 2024 /PRNewsw...